Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T18:40:11.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page history shows Revision: v3.4.2 in place of v3.4.1 in the footer, indicating a minor site update. This change does not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:54:47.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history now includes a new site revision label v3.4.1 and removes v3.4.0. This is a minor platform update and does not affect study data or record content.
    Difference
    0.1%
    Check dated 2026-02-05T01:38:11.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, color-coded highlights (green for additions, red for deletions), and an updated Revision: v3.4.0 label along with wording changes to No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-01-28T22:52:03.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The revision history now includes a new entry for v3.3.4 and removes v3.3.3 from the list, representing a minor update to the record's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T17:49:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer changes include the addition of 'Revision: v3.3.3' and removal of the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:37:12.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.